Tag Archives: Lingering

Krystal Anderson’s Husband Shares Lingering Questions Over Former Kansas City Chiefs Cheerleader’s Death – E! Online – E! NEWS

  1. Krystal Anderson’s Husband Shares Lingering Questions Over Former Kansas City Chiefs Cheerleader’s Death – E! Online E! NEWS
  2. Husband of Kansas City Chiefs Cheerleader Who Died of Sepsis After Stillbirth Speaks Out Against ‘One-Size-Fits-All’ Prenatal Care PEOPLE
  3. Hubby of Ex-Chiefs Cheerleader Speaks Out After Her Post-Stillbirth Sepsis Death The Daily Beast
  4. Husband of Kansas City Chiefs cheerleader who DIED at age 40 from sepsis caused by stillbirth lays bare his bi Daily Mail
  5. Husband of former cheerleader who died after stillbirth describes what happened before her death AOL

Read original article here

ESPN analyst thinks there is lingering friction between Bills’ Josh Allen, Stefon Diggs – Yahoo Sports

  1. ESPN analyst thinks there is lingering friction between Bills’ Josh Allen, Stefon Diggs Yahoo Sports
  2. Robert Griffin III claimed that Stefon Diggs and Josh Allen are having ‘personal’ issues with each other For The Win
  3. Bills’ Stefon Diggs is still putting in work at Fashion Week Buffalo News
  4. Bills QB Josh Allen Blamed for Role in Stefon Diggs Drama Heavy.com
  5. “It’s a Personal Thing”: Stefon Diggs and Josh Allen’s Ongoing Rift Could Be the End of Buffalo’s Dreams, Former QB Opines EssentiallySports
  6. View Full Coverage on Google News

Read original article here

Amritpal episode again shows lingering support for Khalistani sentiments abroad, as backing at home dries up – The Indian Express

  1. Amritpal episode again shows lingering support for Khalistani sentiments abroad, as backing at home dries up The Indian Express
  2. Is Khalistani Movement Reviving Again? | Watch The Full Debate With Rajdeep Sardesai | Punjab News India Today
  3. Punjab Cops’ Meme Message On Fake News Amid Crackdown On Khalistani Leader NDTV
  4. ‘Don’t love the way you lie…’ Punjab Police share meme on fake news amid crackdown on Amritpal Singh PTC News
  5. Hunt For Khalistani Leader Continues, Punjab Police Suspects ISI Angle, Foreign Funding India Today
  6. View Full Coverage on Google News

Read original article here

A lingering question as USA preps for Iran: What’s up with Gio Reyna?

AL RAYYAN, Qatar – It’s the story surrounding the U.S. men’s national team that Gregg Berhalter wishes would stop being talked about. 

The curious case of Giovanni Reyna. 

The 20-year-old winger has been a hot-button topic since before the World Cup began, and not by his own doing. Reyna – the closest thing to U.S. Soccer royalty as the son of two-time U.S. World Cup captain Claudio Reyna and former U.S. women’s national team player Danielle Egan – is one of the brightest young stars on a team full of bright stars. He figured to play a huge role for the Americans in Qatar, but has been mostly absent from the field so far. 

Reyna, who has 15 caps, four goals and one assist since his first call-up in 2020, did not play in the Americans’ first match against Wales and came on in the 83rd minute against England. 

As the U.S. faces World Cup elimination on Tuesday in its third and final group stage match against Iran at Al Thumama Stadium (2 p.m. ET on FOX and the FOX Sports App), a question lingers: What’s the deal with Reyna? 

USMNT’s Gio Reyna on his personal journey to the 2022 FIFA World Cup

The Americans have to win Tuesday to advance to the knockout stage of the tournament. Iran, on the other hand, only needs a tie to move onto the round of 16 thanks to a 2-0 victory over Wales on Friday. 

[For the USMNT, the knockout round has arrived early]

Berhalter’s starting lineup has been mostly the same through two games, except at striker. Josh Sargent started against Wales and Haji Wright got the nod against England. There’s a belief that Jesus Ferreira, the third true striker on this squad, could start against Iran. 

Berhalter was asked on Monday how he would assess the play of his center forwards so far, and if he would consider playing Reyna in that role to give Iran a different look. Berhalter responded by saying that Sargent had a good chance in the near post against Wales and Wright was effective against England. He acknowledged his team could have been better in the penalty box, but “it’s up to the rest of the group to give them quality service so that they can finish off some opportunities.” 

As far as Reyna goes, Berhalter had this to say: “I think in terms of alternatives at the striker position, we are comfortable with the three that we have. We haven’t necessarily thought about putting Gio in there or Christian [Pulisic] there or Timmy Weah there or Jordan Morris there. We’ve been more focused on the three that we have in camp.” 

[Forget tactics and lineups: For USMNT, it’s about having right mentality]

The 6-foot-1 Reyna is a dangerous attacking player when healthy. He’s a smart and technical forward with brilliant ball skills and was the youngest American to appear in the UEFA Champions League in 2020 (then 17), breaking the record formerly set by Pulisic. He’s widely considered to be one of the greatest talents that U.S. Soccer has ever had. 

Over the past year, Reyna experienced injuries that limited his availability for the national team during qualifying and also for his Bundesliga club, Borussia Dortmund. He played in his club’s final three games before the World Cup break and for all intents and purposes, he was deemed a healthy and fit member of Berhalter’s 26-man roster. 

Reyna told reporters that he felt “100% healthy” after the Wales game despite not playing. Berhalter decided to bring on substitutes Brenden Aaronson, Wright, DeAndre Yedlin and Kellyn Acosta while the U.S. led 1-0, and then Morris came on in the 88th minute. Berhalter said that same night that Reyna might have experienced “a little bit of tightness” from a scrimmage earlier in the week against Qatar club team Al-Gharafa SC, and noted they were “building him up and think he can play a big role in the tournament. The question is when.” Reyna then played about 20 minutes in the second match against England.

Asking Berhalter about Reyna’s status has now become A Thing. And the coach appears irritated by the line of questioning. But even former U.S. captain Landon Donovan wants to know what’s going on. 

“He comes into this tournament, we’ve all got him penciled in for the starting lineup and all of a sudden, he doesn’t step on the field against Wales and we’re thinking, ‘What’s going on here?'” Donovan said on FOX before the England match. “I’m not sure what the reality is. He says one thing, Gregg says another. I don’t know, but we need this guy on the field if we’re going to be successful.” 

Perhaps all questions will be answered on Tuesday night in what’s arguably the biggest game in U.S. Soccer history. Or perhaps the mystery could continue.

Iran vs. United States Preview: Will the USMNT make it out of the Group Stage?

Read more from the World Cup:

Best of the rest:

Laken Litman covers college football, college basketball and soccer for FOX Sports. She previously wrote for Sports Illustrated, USA Today and The Indianapolis Star. She is the author of “Strong Like a Woman,” published in spring 2022 to mark the 50th anniversary of Title IX. Follow her on Twitter @LakenLitman.


Get more from FIFA World Cup 2022 Follow your favorites to get information about games, news and more





Read original article here

Hope for long Covid sufferers as Pfizer antiviral for patients left with lingering symptoms trialed

Hope for long Covid sufferers as new study will trial Pfizer’s antiviral Paxlovid in patients left with lingering symptoms months later

  • 100 people who have had long Covid symptoms for 3+ months will take Paxlovid
  • Researchers want to see if it will help with brain fog, fatigue and weakness
  • 1 in 13 US adults suffer with long Covid, and trial results are expected next year

Paxlovid – an antiviral made by Pfizer – is now being looked at as a possible long Covid treatment.

The pharma giant’s flagship Covid drug gained emergency approval in the US last December to treat high-risk patients – slashing their risk of death by 90 per cent.

It is currently the only medication you can take at home to treat Covid and has been given to millions of vulnerable Americans with underlying health conditions.

Now, researchers at Stanford are about to launch the first clinical trial of the drug to see it may also provide relief to people who are still ill months and years after clearing the virus.

Prior research has indicated that people given the drug are a quarter less likely to suffer long Covid – which most commonly causes intense tiredness, brain fog and muscle weakness. 

As of yet, there are no proven treatments for long Covid, and no one knows what causes the ongoing symptoms.

A popular theory is that there may be bits of leftover virus wreaking havoc in the body. A recent study suggested people with long Covid suffer physical alterations to their brain months after clearing the initial infection.

More than 15million Americans are officially estimated to have long Covid to varying degrees.

Trial participants will take the antiviral drug for ten days longer than people usually take it for, to see if it needs longer to work

What is long Covid? 

Long Covid is an informal term, used to describe ongoing symptoms following a Covid infection that go on longer than four weeks, according to the ONS.

A dizzying array of symptoms have been attributed to long Covid, including:

  • extreme tiredness (fatigue)
  • shortness of breath
  • chest pain or tightness
  • problems with memory and concentration (‘brain fog’)
  • difficulty sleeping (insomnia)
  • heart palpitations
  • dizziness
  • pins and needles
  • joint pain
  • depression and anxiety
  • tinnitus, earaches
  • feeling sick, diarrhoea, stomach aches, loss of appetite
  • a high temperature, cough, headaches, sore throat, changes to sense of smell or taste
  • rashes

There is no cure for the condition though the NHS does recommend a number of treatments designed to help alleviate the symptoms.

<!- - ad: https://mads.dailymail.co.uk/v8/de/health/none/article/other/mpu_factbox.html?id=mpu_factbox_1 - ->

Advertisement

The new study hopes to sign up 200 adults who have been negative for Covid for three months yet still suffer symptoms.

Half the participants will receive Paxlovid and half will take a placebo.

To treat an infection, Paxlovid is given as  six pills a day for five days, but participants in the new study will take the drug for 15 days to test the theory that the drug needs more time to have its full effect.

Results of the trial are expected next year.

The first participant in the trial was 67-year-old Bill Fimbres from California, who has been suffering with long Covid symptoms for a year-and-a-half, including a loss of smell and taste, debilitating fatigue and brain fog.

He said: ‘It’s like you have somebody else’s brain.’

Mr Fimbres will take his first dose of either the drug or placebo on Monday.

He told NBC News: ‘If I could get rid of just one of my symptoms, that would be great. I’m just going on hope.’

Evidence indicating Paxlovid might stunt long-term symptoms already exists.

A study by the Department of Veterans Affairs this month suggested those who received the drug immediately after their Covid diagnosis were 26 per cent less likely than those who did not take the antiviral to have lasting symptoms three months on. 

However, the participants were all aged 60 or above with additional health issues, meaning the findings may not be applicable to everyone. 

Long Covid has puzzled scientists and physicians since it first popped on their radar in 2020.

Its causes have not been figured out, but experts believe it could be tied to the body’s immune response to the virus. 

There have also been previously known cases of people suffering long-term symptoms after suffering more common viruses like the flu.

The CDC estimates that around 7.5 per cent of American adults are suffering from long Covid symptoms.

Sufferers are generally under the age of 50, and are more likely to be women. Reports of long Covid are most common in southern states like Kentucky and Alabama. 

Read original article here

Coronavirus cases: Research sheds light on an emerging parallel COVID epidemic amid new variant, lingering symptoms

LOS ANGELES — Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth. With concern over COVID waning, a parallel pandemic is emerging.

READ MORE | Long COVID symptoms plague sufferers, but new studies could lead to treatments and relief

“We’re still learning about the long term health effects of COVID infections,” said Los Angeles County Public Health Director Barbara Ferrer.

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

READ MORE | Long haul COVID in kids symptoms, lingering effects still poorly understood

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

READ MORE | Future uncertain for COVID ‘long-haulers’ struggling with chronic illness

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here

Coronavirus cases: Research sheds light on an emerging parallel COVID epidemic amid new variant, lingering symptoms

LOS ANGELES — Because so many people have dealt with COVID-19 infections, many now view the virus like a common cold or flu.

New research suggests that’s far from the truth.

With concern over COVID waning, a parallel pandemic is emerging.

“We’re still learning about the long term health effects of COVID infections,” said Los Angeles County Public Health Director Barbara Ferrer.

SEE ALSO | 80% with long COVID have debilitating conditions: CDC

Dr. Michael Ghobrial with the Cleveland Clinic said they’re seeing it more commonly in younger patients.

This comes as doctors across the country are dealing with a growing number of patients who can’t shake their initial COVID symptoms or have acquired new symptoms that last for at least a month or more. Some cases have been going on for two years.

“The most described symptoms of long COVID include fatigue, reduced exercise capacity, breathing problems, brain fog and loss of taste or smell,” said Ferrer.

Various studies find long COVID, or long haulers syndrome, can strike in all populations.

“It’s more in females compared to males. It’s also more common in patients who have comorbidities,” said Ghobrial.

In a study of several thousand veterans, Ferrer said the new evidence suggests repeated COVID infections increase one’s risk for long haul syndrome.

RELATED | COVID US: CDC drops traveler health notices for individual countries

“Many of these disorders were serious and life changing and included stroke, cognition and memory disorders, peripheral nervous system disorders,” she said. “The risk of having long term health conditions was three times higher for those infected three times compared to those who were uninfected.”

Avoiding infection is the key, and while COVID vaccines and boosters don’t always prevent infection, numerous studies find it can reduce the risk of long COVID.

“Those who had two doses of vaccine before getting COVID had an approximately 75% lower chance of getting long COVID,” said Ferrer. “While those who got three doses had an 84% lower chance of getting long COVID.”

While we have much to learn, Ferrer said getting vaccinated and boosted appears to be one of the simplest ways to significantly reduce your risk.

Copyright © 2022 KABC Television, LLC. All rights reserved.



Read original article here

A Key to Long Covid Is Virus Lingering in the Body, Scientists Say

The virus that causes Covid-19 can remain in some people’s bodies for a long time.  A growing number of scientists think that lingering virus is a root cause of long Covid.

New research has found the spike protein of the SARS-CoV-2 virus in the blood of long Covid patients up to a year after infection but not in people who have fully recovered from Covid. Virus has also been found in tissues including the brain, lungs, and lining of the gut, according to scientists and studies 

The findings suggest that leftover reservoirs of virus could be provoking the immune system in some people, causing complications such as blood clots and inflammation, which may fuel certain long Covid symptoms, scientists say. 

A group of scientists and doctors are joining forces to focus research on viral persistence and aim to raise $100 million to further the search for treatments. Called the Long Covid Research Initiative, the group is run by the PolyBio Research Foundation, a Mercer Island, Wash., based nonprofit focused on complex chronic inflammatory diseases. 

Amy Proal, a microbiologist at PolyBio and chief scientific officer of the Long Covid Research Initiative



Photo:

Amy Proal

“We really want to understand what’s at the root of [long Covid] and we want to focus on that,” says Amy Proal, a microbiologist at PolyBio and the initiative’s chief scientific officer. Dr. Proal has devoted her career to researching chronic infections after developing myalgic encephalomyelitis/chronic fatigue syndrome, an illness that shares similar symptoms with long Covid, in her 20s. 

Three long Covid patients, frustrated at the lack of answers and treatments, have helped connect researchers. 

“Long Covid is this really incredible emergency,” says Henry Scott-Green, one of the patients, a 28-year-old in London who says brain fog, extreme fatigue and other debilitating long Covid symptoms prevented him from resuming full-time work as a product manager, though he plans to return soon. “We’re really trying to run really efficiently and cut out as many layers of bureaucracy as possible.”

So far, the group says it has received a pledge of $15 million from Balvi, an investment and direct giving fund established by Vitalik Buterin, the co-creator of the cryptocurrency platform Ethereum. 

Henry Scott-Green says debilitating long Covid symptoms have prevented him from resuming full-time work.



Photo:

Long Covid Research Initiative

Among the strongest evidence of viral persistence in long Covid patients is a new study by Harvard researchers published Friday in the journal of Clinical Infectious Diseases. Researchers detected the spike protein of the SARS-CoV-2 virus in a large majority of 37 long Covid patients in the study and found it in none of 26 patients in a control group.

Patients’ blood was analyzed up to a year after initial infection, says

David R. Walt,

a professor of pathology at Brigham and Women’s Hospital in Boston and Harvard Medical School and lead researcher of the study. Dr. Walt isn’t currently involved with the long Covid initiative. 

A year after infection, some patients had levels of viral spike protein that were as high as they did earlier in their illness, Dr. Walt says. Such levels long after initial infection suggest that a reservoir of active virus is continuing to produce the spike protein because the spike protein typically doesn’t have a long lifetime, he adds.

Dr. Walt plans to test antivirals such as Paxlovid or remdesivir to see if the drugs help clear the virus and eliminate spike protein from the blood.  He says it’s possible that for some people, the normal course of medication isn’t enough to clear the virus. Such cases may require “a much longer exposure to these antivirals to fully clear,” says Dr. Walt.

One of the research group’s goals is to find a way for people to identify whether they continue to have the virus in their bodies. There is no easy way to determine this now. 

New studies offer clues about who may be more susceptible to long Covid, a term for lingering Covid-19 symptoms. WSJ breaks down the science of long Covid and the state of treatment. Illustration: Jacob Reynolds for The Wall Street Journal

Long Covid patients experience such a wide range of long-term symptoms that scientists think there is likely more than one cause, however. Some cases may be fueled by organ damage, for instance. 

Yet consensus is growing around the idea that lingering virus plays a significant role in long Covid. Preliminary research from immunologist Akiko Iwasaki’s laboratory at Yale University documented T or B cell activity in long Covid patients’ blood, suggesting that patients’ immune systems are continuing to react to virus in their bodies. Dr. Iwasaki is a member of the new initiative. 

In a 58-person study published in the Annals of Neurology in March, University of California, San Francisco researchers also found SARS-CoV-2 proteins circulating in particles in long Covid patients’ blood, especially in those with symptoms such as fatigue and trouble concentrating.

Now, the group is completing a study using imaging techniques and tissue biopsies to detect persistent virus or reactivation of other viruses in tissue. It also is looking at T-cell immune responses in tissues and whether they correlate with symptoms. 

Some people may harbor the virus and don’t have long-term symptoms, says Timothy Henrich, an associate professor of medicine at UCSF involved with the study and a member of the long Covid initiative. For others, lingering virus may produce problems.

“I think there’s a real amount of mounting evidence that really suggests that there is persistent virus in some people,” says Dr. Henrich.  

Write to Sumathi Reddy at Sumathi.Reddy@wsj.com

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Read original article here

Freddie Freeman’s lingering free agency saga is rife with tears, anger and blame

We’re all suckers for it. The departed free agent returns to where he started. Fans shower him with affection. Tears are shed, hugs exchanged. The passage of time makes the bittersweet moment less bitter, more sweet.

That’s what you thought you were seeing when Freddie Freeman returned last weekend to Atlanta, right? Well, we know now an undercurrent of anger fueled Freeman’s emotion, the bitter rivaling, perhaps even surpassing, the sweet.

Freeman’s decision to leave the Braves for the Dodgers was one of the most regrettable free-agent outcomes in recent memory, and one for which every party — the Braves, Freeman’s agents at Excel Sports Management, Freeman himself — bears responsibility.

The episode reflected much of what is wrong with professional sports in the 21st century. Teams more concerned with payroll efficiency than showing loyalty to players who rewarded them. Agents more concerned with setting a financial standard than honoring the wishes of their clients. Fan favorites bolting for other clubs because … well, why exactly?

Freeman’s decision to join the Dodgers on a six-year, $162 million free-agent contract seemed unfortunate the moment it happened more than three months ago. It looked even worse over the weekend, when Freeman shed enough tears to irrigate the playing surface at Truist Park for the next three months.

And incredibly, the saga is still not over.

On Sunday night, during ESPN’s broadcast of the Dodgers-Braves series finale, all baseball agents received a “do not contact Freddie Freeman” email from the Major League Baseball Players Association. The union only issues such orders at a player’s request. In such cases, the player generally wants to avoid being overwhelmed by calls or messages from his previous agency, or other agents interested in representing him.

Multiple agents said Sunday night that Freeman had decided to fire Excel. Freeman declined comment to The Athletic on Sunday and again on Monday. Casey Close, the lead agent at Excel, did not respond to requests for comment.

ESPN reported Tuesday that Freeman had left Excel, but Freeman still would not publicly confirm, describing the situation as “fluid.” At this point, it would be a shock if Freeman stayed with the agency. Perhaps he is just not ready, for whatever reason, to make the news official.

Freeman, 32, finally seems to understand he needs to move on, telling reporters Tuesday, “there needs to be closure,” after telling me in an interview for Fox Sports on Saturday, “I’m not looking to have any closure. I don’t want to close something that was so special to me for 15 years.” But to borrow a term that is frequently invoked by players, all of the parties involved need to “wear it.” One by one, here’s why:

The Braves

Let’s start with the Liberty Media ownership, which reported $568 million in total Braves revenue for 2021, a season in which, ahem, Freeman helped lead the team to its first World Series title in 25 years.

Liberty Media and the Blue Jays’ parent company, Rogers Communications, are the only two major-league ownerships that, as publicly traded entities, must report their earnings. The Braves’ success, both on the field and in the Liberty-owned Battery development adjacent to Truist Park, prompted Liberty to establish a second-straight payroll record, jumping from $131.4 million on Opening Day in 2021 to $177.8 million in ’22.

So, why draw the line with Freeman?

That choice, it seemed, rested largely with president of baseball operations Alex Anthopoulos, who, despite Liberty’s recent largesse, does not operate with unlimited resources. The Braves, even after their payroll boost, rank only ninth in the majors. So when Anthopoulos in Aug. 2021 offered Freeman a five-year, $135 million extension — $5 million more than the Cardinals gave an arguably superior first baseman, Paul Goldschmidt — he might not have been comfortable going much further. Whether he increased the offer to $140 million once Freeman was a free agent is in dispute.

My belief — and the belief of a number of agents and executives in baseball — is that Anthopoulos preferred the matter to play out precisely how it did, with the Braves trading for a younger, cheaper reasonable facsimile of Freeman, Matt Olson. Is Olson as good as Freeman right now? Probably not. But his eight-year, $168 million contract covers his age 28 to 35 seasons. Freeman’s deal with the Dodgers covers his age 32 to 37 campaigns.

Olson cost the Braves four prospects in their trade with the Athletics, but his $21 million average annual value left the team with more payroll flexibility than Freeman would have at $27 million or $28 million per. The Braves, who excel in scouting and player development, included catcher Shea Langeliers as the centerpiece of their deal with the A’s in part because they had another young catcher, William Contreras, who is emerging this season as a potential star.

Anthopoulos and the Braves, then, could very well end up looking smart. Their fans had no problem embracing Olson, who grew up in Lilburn, Ga. But Freeman was an immensely popular homegrown talent, a worthy heir to Hall of Famer Chipper Jones, precisely the kind of player who should spend his entire career with one team. If the Braves truly wanted him, they did not push hard enough.

Excel

The emotions Freeman displayed in Atlanta made it obvious that he is sensitive. He said he made it clear to Excel from the outset of discussions with the Braves that he wanted to stay in Atlanta. At that point, Excel’s mission should have been clear. Talk to other teams. Exert as much leverage as possible. But in the end, cut the best deal possible with the Braves.

Freeman wanted six guaranteed years, or at least, Excel wanted six guaranteed years for him. Excel can point to two superior offers made by the low-revenue Rays, according to ESPN  — six years, $140 million or seven years, $150 million — as evidence that the Braves did not make a sufficient effort. But Excel should have known its client and known how he would react to leaving the Braves. If Freeman’s overwhelming priority was to be in Atlanta, nothing else should have mattered.

Excel will collect the commission on Freeman’s deal with the Dodgers, which at the standard baseball rate of 5 percent would be $8.1 million over the course of the deal. The loss of Freeman, however, would mark the second high-profile departure of a newly signed free-agent client from the agency in the past two months. Second baseman Trevor Story, who signed a six-year, $140 million contract with the Red Sox in a deal that became official on March 20, switched to Wasserman Baseball at the end of April.

Freeman had reason to trust Excel, which negotiated his eight-year, $135 million extension with the Braves in Feb. 2014. The agency, highly respected, represents Hall of Famer Derek Jeter as well as a number of current stars, including Goldschmidt, Clayton Kershaw, Kyle Schwarber, George Springer and — ahem — current Braves shortstop Dansby Swanson, who is in his walk year.

Excel, though, should have anticipated Freeman’s reaction. The agency ultimately secured a sixth guaranteed year from the Dodgers, but to what end? Freeman’s $162 million deal, considering higher tax rates in California and deferred payments in the contract, might be comparable in net value to the $135 million the Braves are known to have offered. And according to sources, one of Freeman’s motivations for leaving Excel would be to prevent the agency from trumpeting his deal as its latest triumph.

Freddie Freeman

So, who was running the show here, anyway? Freeman doesn’t work for Excel; the agency works for him. And it’s Freeman’s fault, more than anyone else’s, if he did not end up exactly where he wanted.

As much as he might have thought he made his desires clear to Close and Victor Menocal, the Excel representative with whom he usually communicated, Freeman should have been more directly involved in the process. He is not the first player influenced by his agent to seek the biggest contract over the most comfortable landing spot. He also would not have been the first player to overrule his agent even if it meant less money for both parties.

That said, Freddie doth fret too much.

The Dodgers were not exactly an undesirable landing spot for Freeman, who is from Orange County in Southern California. Freeman and his wife, Chelsea, have spent offseasons at their oceanside house in Corona Del Mar, an hour from L.A. And the team has made nine straight postseason appearances, an even more impressive run than the Braves’ four straight division titles.

Freeman, if he indeed leaves Excel, would not need an agent for contract negotiations until his current deal expires, and an attorney or business manager can help him with endorsements and other matters. He’s going to be just fine, though no one should be surprised if his outpouring of emotions last weekend raised eyebrows among his new teammates.

Kershaw seemed to send a not-so-subtle message to Freeman, telling the Atlanta Journal-Constitution, “I hope we’re not second fiddle. It’s a pretty special team over here, too.” Dodgers manager Dave Roberts, though, defended his new first baseman’s reaction, telling The Athletic’s Fabian Ardaya, “If anyone has a problem with it, that’s on them. It shouldn’t be a problem. This guy has helped us win a s—-ton of games this year and will continue to do so.”

Fair enough, but last weekend turned out to be less a celebration than a realization of all that went wrong. A player, team and agency, all accomplished, combined to produce an unfortunate and unnecessary outcome. Too much bitter, not enough sweet.

(Top photo of Freddie Freeman: Bob Andres / Associated Press)



Read original article here

Sandra Bullock gets a lingering look from co-star Channing Tatum at The Lost City premiere

They recently said they would remain ‘friends for life’ after filming together.  

And Sandra Bullock and Channing Tatum looked the best of pals at the UK premiere of The Lost City in London’s Leicester Square on Thursday.  

Channing, 41, looked dapper in a simple black trouser suit as he cast a lingering look at his glam co-star. 

Pals: Sandra Bullock gets a lingering look from co-star Channing Tatum on the green carpet at The Lost City premiere in London on Thursday 

The Magic Mike star teamed the look with a matching polo neck while placing his hand in his trouser pocket. 

Channing finished off the look with a pair of dress shoes while looking suave posing with with his arm around his co-stars waist.

Meanwhile, Hollywood icon Sandra, 57, showed off her style credentials in a chic black trouser suit with a contrasting pink cape.

Bond: They recently said they would remain ‘friends for life’ after filming together

The actress wowed in the stunning ensemble which was embellished by a pink and purple caped belted detailing.

The belt fell from the star’s svelte waist flowed behind her as she posed on the green carpet for the premiere.

She completed her look with black pointed-toe heels while wearing her brunette tresses in a mass of dramatic curls.

Wow: Hollywood icon Sandra, 57, showed off her style credentials in a chic black trouser suit with a contrasting pink cape

The outing comes as earlier this month Sandra described how she stayed focused while filming with an almost nude Channing in an episode of The Late Show with Stephen Colbert. 

The Speed actress described how in their new movie she was in front of his crotch but tried instead to divert her eyes and focus on his thigh.

The screen icon plays a shut-in author who gets kidnapped and has a scene where she has to help Channing, who plays a romance novel cover model, peel leeches off his body. 

Suave: The Magic Mike star teamed the look with a matching polo neck while placing his hand in his trouser pocket

 

Plot: Sandra plays a shut-in author who gets kidnapped and has a scene where she has to help Channing, who plays a romance novel cover model, peel leeches off his body

|Stunner: The actress wowed in the stunning ensemble which was embellished by a pink and purple caped belted detailing

Wow: She completed her look with black pointed-toe heels while wearing her brunette tresses in a mass of dramatic curls

Handsome: Channing looked the typical Hollywood icon as he posed at the star-studded event 

New movie: Sandra Bullock described how she stayed focused while filming with an almost nude Channing Tatum on Monday’s episode of The Late Show with Stephen Colbert

‘He’s full on Fabio,’ said Sandra.

‘He’s more than that he’s full on Monty,’ said Stephen, 57. ‘Let’s sell some tickets right now, Sandy.’

‘He’s stupid naked in this film,’ said Sandra.

Stephen said there was a full on shot of his butt.

Leeches scene: Sandra plays a shut-in author who gets kidnapped and has a scene where she has to help Channing, who plays a romance novel cover model, peel leeches off his body

Sandra said not really.

‘There is a full cheek…but I don’t believe we showed the full left cheek,’ said Sandra.

‘Ninety percent of the left cheek,’ said Stephen, who then said there was a moment when Channing’s character turned around so she could check his front. ‘Was that CGI?’

Only partial: ‘There is a full cheek…but I don’t believe we showed the full left cheek,’ said Sandra

Good times: ‘Fully there,’ said Sandra laughing. ‘Full on, face to face, with the landscape …I had to spend some time down there.’

 ‘No,’ said Sandra.

‘You are there?’ asked Stephen.

‘Fully there,’ said Sandra. ‘Full on, face to face, with the landscape …I had to spend some time down there.’

Stephen said her character was reacting as if he was well endowed.

‘When you are down there and you have two pages of dialogue, if you are looking directly at it you will get nothing done,’ said Sandra. ‘So I looked at his left thigh.’ 

Funny: The outing comes after earlier this month Sandra described how she stayed focused while filming with an almost nude Channing in an episode of The Late Show with Stephen Colbert

Read original article here